Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SRPT
SRPT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SRPT News
Sarepta Therapeutics Q1 Results Beat Expectations Despite Stock Decline
4d ago
seekingalpha
FDA Leadership Shakeup May Impact Biotech Stocks
2d ago
stocktwits
Sarepta Therapeutics Q1 2026 Earnings Call Insights
3d ago
seekingalpha
Sarepta's Q1 Results Beat Expectations but Shares Drop
4d ago
stocktwits
Sarepta Therapeutics Q1 Earnings Exceed Expectations
4d ago
seekingalpha
Sarepta Therapeutics to Report Q1 2026 Financial Results
Apr 22 2026
Newsfilter
Transformation of Value in Biotechnology Sector
Apr 20 2026
Globenewswire
Biotechnology Sector Undergoes Value Transformation
Apr 20 2026
Newsfilter
Roche Initiates New Phase 3 Trial for Elevidys Gene Therapy
Apr 16 2026
seekingalpha
Capricor's Former Executive Considered for FDA Biologics Chief
Apr 14 2026
stocktwits
SAREPTA THERAPEUTICS INC: RBC Increases Target Price from $18 to $19
Apr 07 2026
moomoo
SAREPTA THERAPEUTICS, INC.: DEUTSCHE BANK INCREASES TARGET PRICE FROM $12 TO $14
Mar 26 2026
moomoo
SAREPTA THERAPEUTICS INC: WEDBUSH INCREASES TARGET PRICE FROM $29 TO $35
Mar 26 2026
moomoo
SAREPTA THERAPEUTICS INC: CITIGROUP INCREASES TARGET PRICE FROM $9 TO $13
Mar 26 2026
moomoo
SAREPTA THERAPEUTICS INC: PIPER SANDLER INCREASES TARGET PRICE FROM $16 TO $23
Mar 26 2026
moomoo
Sarepta's Promising Data Sparks Market Optimism
Mar 25 2026
stocktwits
Show More News
